UNSPSC 51373326: Aspirin/carisoprodol/codeine

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class CN101. This VA Drug Class (CN101) classifies this compound as belonging to the group OPIOID ANALGESICS.

UNSPSC 51373326 Aspirin/carisoprodol/codeine is a Commodity code that shows minimal relevance to current state and local procurement activity. The sole recent opportunity in the dataset—Seminole County, Florida's IFB 60459723LAS, posted June 30, 2026—solicits naloxone and safe drug deactivation systems rather than the opioid analgesics and muscle relaxants nominally covered by this code's name. The mismatch between the code's pharmaceutical scope and the actual procurement (emergency-response and harm-reduction supplies) suggests either miscoding at the point of solicitation or a fundamental divergence between the UNSPSC taxonomy assignment and what state and local purchasing offices are actually buying under this designation.

Seminole County, a county government in central Florida, issued the naloxone and drug deactivation systems IFB with a response deadline of July 26, 2023 (though the posting date of June 30, 2026 in the system record appears inconsistent with the cited bid dates). The contract calls for annual procurement of 1,900 units of naloxone and 800 safe drug deactivation systems with quarterly deliveries to the Seminole County Community Health Building; the contract offers a two-year initial term with one-year renewal option. No other recent state and local opportunities under this code appear in the dataset. Bidders must comply with E-Verify, drug-free workplace certification, and applicable federal requirements given potential FEMA funding. Until additional opportunities surface, this code shows no meaningful procurement volume or geographic spread across state and local jurisdictions.